Pregnant people nearly twice as likely to develop breakthrough COVID, study suggests
Results from a new study suggest pregnant people who are vaccinated against COVID-19 are almost twice as likely to develop breakthrough COVID than those who are not pregnant, The Washington Post reports.
In fact, fully-vaccinated pregnant people "have the greatest risk of developing COVID among a dozen medical states, including being an organ transplant recipient and having cancer," per the Post. The study was based on the medical records of roughly 14 million U.S. patients from the time vaccines first became available.
Findings underscore other research showing how pregnant people or individuals that gave birth recently and contracted COVID are "especially prone" to getting seriously ill from the virus. But this new study extends beyond what "was previously understood" in that it suggests even fully-vaccinated pregnant people "tend to have less protection from the virus than many other patients with significant medical problems."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"If you are fully vaccinated, that's magnificent," said a lead author of the study, David Little. "But if you are fully vaccinated and become pregnant, you remain at higher risk of acquiring covid."
The analysis found that the 110,000 pregnant people included in the study were "90 percent more likely to have been infected with coronavirus than the same number of people who were not pregnant," the Post writes. Those at the next-highest level of risk were organ transplant recipients. And both of those groups shockingly bested immunocompromised patients, who had 60 percent greater odds of coronavirus infection.
Excluded from these findings, however, is the reasoning behind them. "It's definitely interesting," specialist Denise Jamieson told the Post. "This study asks this question but doesn't answer it." Read more at The Washington Post.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published